Pinch Med, Inc.

Based in Illinois, US, and founded in 2022 by Chief Executive Officer Elan Mosbacher and Chief Medical Officer Jacob Avraham, Pinch Med, Inc. operates as a provider of an online platform that enables customers to allow consultation, scheduling, and booking of botulinum injectable and dermal filler procedures at home, office, and hotel. In April 2024, Pinch Med, Inc. raised USD 3.

5 million in seed funding led by Starting Line with participation from Lightbank, Ludlow Ventures, The 81 Collection, and Permanent Capital. Pinch Med, Inc. provides personalized med spa treatments delivered to clients and patients' homes, hotels, and offices. The company’s product offerings include a variety of aesthetic treatments such as Tox (commonly known as Botox), filler injections, chemical peels, and IV therapy.

In addition, the firm provides a variety of solutions for treatment areas including bunny lines, crow's feet, gummy smile, migraines, cheek enhancement, chin augmentation filler, biorepeel, VI peel, and IV therapy treatment at home. It offers a search engine for locating pinch providers.   The company generates revenue by charging for its services and charges USD 12 per unit for the Tox Treatment Guide. The firm charges USD 399 per syringe for the Filler Treatment Guide and USD 299 per pinch (BioRePeel) for the Chemical Peels Treatment Guide.

It charges USD 250 per pinch for an IV Therapy Treatment Guide and USD 150 per pinch for the add-on. The company plans to use the funding in April 2024 to accelerate the development of its management and operation.